Latest Breaking News On - National autism research center - Page 1 : comparemela.com

SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in

The clinical trial for SCI-210 will be conducted in Israel, after which the company aims to move forward with the commercialization process of SCI-210 first in the Israeli market

Oz adlerScisparc palmitoylethanolamideScisparc ltdCompany or scisparcNational autism research centerSoroka medical centerExchange commissionChief executive officerAberrant behavior checklist communityClinical global impressions improvementTourette syndromeLooking statementsPrivate securities litigation reform actAnnual report

New Hope for Children: SciSparc s patented CBD- Enhanced Solution for Autism Spectrum Disorder -November 24, 2023 at 08:55 am EST

TEL AVIV, Israel, Nov. 24, 2023 SciSparc Ltd. , a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare disease of the central.

Oz adlerNational autism research centerCompany or scisparcSoroka medical centerGlobenewswire incScisparc ltdExchange commissionMedical centerAutism spectrum disorderChief executive officerAutism research centerTourette syndromeLooking statementsPrivate securities litigation reform actAnnual report

SciSparc (SPRC) has initiated a clinical trial using its proprietary therapy

SciSparc (SPRC) has initiated a clinical trial using its proprietary therapy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Oz adlerCompany or scisparcScisparc ltdSoroka medical centerNational autism research centerAutism spectrum disorderChief executive officer

New Hope for Children: SciSparc s patented CBD- Enhanced Solution for Autism Spectrum Disorder -November 24, 2023 at 08:56 am EST

TEL AVIV, Israel, Nov. 24, 2023 SciSparc Ltd. , a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare disease of the central.

Oz adlerNational autism research centerExchange commissionSoroka medical centerCompany or scisparcScisparc ltdAutism spectrum disorderChief executive officerTourette syndromeLooking statementsPrivate securities litigation reform actAnnual report

New Hope for Children: SciSparc s patented CBD- Enhanced

TEL AVIV, Israel, Nov. 24, 2023 (GLOBE NEWSWIRE) SciSparc Ltd. (Nasdaq: SPRC) (

Oz adlerNational autism research centerSoroka medical centerCompany or scisparcScisparc ltdExchange commissionAutism spectrum disorderChief executive officerTourette syndromeLooking statementsPrivate securities litigation reform actAnnual reportNasdaq sprcScisparc ltdClinical trial